MUV completes the divestiture of its Meetings & Events unit to miMeetings, streamlining its operations to prioritize clinical trial patient transportation services across its global network.
MUV completed the sale of its Meetings & Events division to miMeetings, making clinical trial patient transportation its core business. No sale price, proceeds or earnings impact is disclosed, so the transaction cannot be valued from the release. The strategic refocus is clear, but without figures the near-term share-price effect is likely limited.
MUV sold its Meetings & Events division to miMeetings.
Clinical trial patient transportation, supported by a network of certified patient drivers.
MUV has finalized the sale of its Meetings & Events division to miMeetings, marking a strategic pivot toward a single-focus business model. The company will now dedicate its operations exclusively to clinical trial patient transportation, leveraging its network of certified drivers to support the development of new medical therapies.
MUV sold its Meetings & Events division to miMeetings.
Clinical trial patient transportation, supported by a network of certified patient drivers.